Mitsubishi UFJ Asset Management UK Ltd. Sells 1,000 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Mitsubishi UFJ Asset Management UK Ltd. decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 40.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,500 shares of the healthcare conglomerate’s stock after selling 1,000 shares during the quarter. Mitsubishi UFJ Asset Management UK Ltd.’s holdings in UnitedHealth Group were worth $759,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Kathleen S. Wright Associates Inc. bought a new position in UnitedHealth Group in the 3rd quarter worth approximately $27,000. Global Wealth Strategies & Associates boosted its stake in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares in the last quarter. West Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $32,000. Quarry LP increased its stake in shares of UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC purchased a new stake in UnitedHealth Group during the 3rd quarter valued at $37,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 2.9 %

NYSE:UNH opened at $524.78 on Wednesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a 50-day simple moving average of $547.07 and a 200 day simple moving average of $563.84. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a market capitalization of $482.95 billion, a price-to-earnings ratio of 33.86, a price-to-earnings-growth ratio of 1.38 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the business earned $5.83 earnings per share. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.77 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. UnitedHealth Group’s payout ratio is 54.19%.

Analyst Ratings Changes

Several equities analysts have recently commented on UNH shares. Royal Bank of Canada lowered their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. TD Cowen lifted their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Bank of America lowered their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Finally, Oppenheimer increased their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Two investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $627.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.